carboxypeptidase-G2
Term · Oncology and biomedicine · MLC-T-ONC-001423
A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Carboxypeptidase-G2 is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Carboxypeptidase-G2 is a type of chemoprotective agent and a type of prodrug activator. Also called glucarpidase and Voraxaze.
| Identifier | MLC-T-ONC-001423 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | glucarpidase; Voraxaze |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001423",
"term": "carboxypeptidase-G2",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Carboxypeptidase-G2 is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Carboxypeptidase-G2 is a type of chemoprotective agent and a type of prodrug activator. Also called glucarpidase and Voraxaze.",
"synonyms": [
"glucarpidase",
"Voraxaze"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/carboxypeptidase-g2/"
}
Record 4,214 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.